Clinical Fellow in TYA Haematology/Oncology
| Posting date: | 09 January 2026 |
|---|---|
| Salary: | Not specified |
| Additional salary information: | £52,656 per annum + London weighting (+out-of-hours) |
| Hours: | Full time |
| Closing date: | 08 February 2026 |
| Location: | London, NW1 2BU |
| Company: | University College London Hospital |
| Job type: | Contract |
| Job reference: | 7709925/309-UCLH-7266 |
Summary
A Vacancy at University College London Hospitals NHS Foundation Trust.
We have an exciting opportunity for a Trust Doctor in TYA Haematology/Oncology(SHO/ST1+ equivalent), to join our busy and innovative Children’s and Young People’sCancer Services [CYPCS] at UCLH from March 2026 on a 6-month fixed term contract. It is a 40-hour post: 08:30am-5pm Monday to Friday, with on call commitments which include:
evening shifts, weekends and nights, as part of a 1:10 rota to include general and acutepaediatrics.
You will be joining a friendly team to provide an excellent and comprehensive TYAHaematology/Oncology service within UCL Hospitals NHS Foundation Trust. There arenumerous in-house training/teaching opportunities, including: Wednesday weeklyafternoon teaching with Whittington and Royal Free Hospitals, journal clubs, and you willbe encouraged to undertake: audit projects and guideline development, clinical trials assub-investigator, clinical research projects, and more!
This post will be comprised of 80% clinical activity and 20% for special interest activities, including disease focused research, service development projects, leadership and management skills training, diagnostics lab attachments.
With consultant supervision, you will be responsible for the day-to-day management of patients on the inpatient service based in the UCLH main hospital building (T11 for paediatric patients, T12 for teenagers). You will be working alongside Specialty Registrars, Advanced Nurse Practitioners and the nursing team in ensuring the daily review of the inpatients, admissions/discharges, treatment planning and allocation (after
appropriate training and sign-off).
As part of the job, you will have the chance to develop expertise in a variety of subspecialities:
- Acute and chronic leukaemias
- Hodgkin and non-Hodgkin lymphomas
- Non malignant haematology
- Neuro-oncology
- Sarcomas
- Rare tumours
- Bone Marrow Transplant (autologous and allogeneic)
- CAR T cells therapy
- Proton Beam Therapy
- Lab diagnostics (flow cytometry/cytogenetics/molecular/histopathology)
We also have a wide portfolio of clinical trials in all disease subtype, and you will have the opportunity to be actively involved as a sub-investigator.
University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research.
We provide first-class acute and specialist services across eight sites:
• University College Hospital (incorporating the Elizabeth Garrett Anderson Wing)
• National Hospital for Neurology and Neurosurgery
• Royal National ENT and Eastman Dental Hospitals
• University College Hospital Grafton Way Building
• Royal London Hospital for Integrated Medicine
• University College Hospital Macmillan Cancer Centre
• The Hospital for Tropical Diseases
• University College Hospital at Westmoreland Street
We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women’s health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.
We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.
For the full Person Specification and more information regarding the main responsibilities of this role, please refer to the attached Job Description.
Please note, due to anticipated high volumes of applications, this vacancy may close earlier than the listed closing date. You are advised not to delay submitting your completed application
The TYA Service at UCLH is the largest in the world, attracting an international
reputation, with regular visits from experts from around the globe. We provide
comprehensive tertiary care for patients from diagnosis, through to survivorship or palliative care. We provide all aspects of state-of-the-art cancer care and are a quaternary centre for specific treatments, including radio-isotope therapy and proton beam therapy. The clinical service is enhanced by exceptional clinical and translational research based within University College London and the Institute of Child Health.
All patients aged 0-18 years with a diagnosis of cancer, within the North Thames TYA Cancer Network are referred into the UCLH/GOSH Principal Treatment Centre. Patients aged 19-24 years are offered the choice to be referred to UCLH or to be treated at local Designated Hospitals within the Operational Delivery Network (ODN).
The newly opened Grafton Way Hospital houses the Proton Beam Therapy (PBT) Centre, one of only two sites in the UK. PBT offers innovative radiotherapy for certain cancer patients, with children making a significant proportion providing new models of care, synergistic clinical provision and research opportunities. These children require extensive supportive and POSCU-like care, offering opportunities for the development of
new services linking acute paediatrics, CYPCS and radiotherapy.
Come and be a part of the best NHS trust in England to work for, according to our staff*
* UCLH top trust to work at in England - In the most recent NHS staff survey UCLH had the highest percentage of staff who said they would recommend us as a place to work, out of all general acute or acute/community NHS trusts in England – for the third year in a row.
UCLH recognises the benefits of flexible working for staff – To find out more, visit: Flexible working.
To discover more about what makes UCLH a great place to work, visit: Why Choose UCLH?
This advert closes on Sunday 1 Feb 2026
We have an exciting opportunity for a Trust Doctor in TYA Haematology/Oncology(SHO/ST1+ equivalent), to join our busy and innovative Children’s and Young People’sCancer Services [CYPCS] at UCLH from March 2026 on a 6-month fixed term contract. It is a 40-hour post: 08:30am-5pm Monday to Friday, with on call commitments which include:
evening shifts, weekends and nights, as part of a 1:10 rota to include general and acutepaediatrics.
You will be joining a friendly team to provide an excellent and comprehensive TYAHaematology/Oncology service within UCL Hospitals NHS Foundation Trust. There arenumerous in-house training/teaching opportunities, including: Wednesday weeklyafternoon teaching with Whittington and Royal Free Hospitals, journal clubs, and you willbe encouraged to undertake: audit projects and guideline development, clinical trials assub-investigator, clinical research projects, and more!
This post will be comprised of 80% clinical activity and 20% for special interest activities, including disease focused research, service development projects, leadership and management skills training, diagnostics lab attachments.
With consultant supervision, you will be responsible for the day-to-day management of patients on the inpatient service based in the UCLH main hospital building (T11 for paediatric patients, T12 for teenagers). You will be working alongside Specialty Registrars, Advanced Nurse Practitioners and the nursing team in ensuring the daily review of the inpatients, admissions/discharges, treatment planning and allocation (after
appropriate training and sign-off).
As part of the job, you will have the chance to develop expertise in a variety of subspecialities:
- Acute and chronic leukaemias
- Hodgkin and non-Hodgkin lymphomas
- Non malignant haematology
- Neuro-oncology
- Sarcomas
- Rare tumours
- Bone Marrow Transplant (autologous and allogeneic)
- CAR T cells therapy
- Proton Beam Therapy
- Lab diagnostics (flow cytometry/cytogenetics/molecular/histopathology)
We also have a wide portfolio of clinical trials in all disease subtype, and you will have the opportunity to be actively involved as a sub-investigator.
University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research.
We provide first-class acute and specialist services across eight sites:
• University College Hospital (incorporating the Elizabeth Garrett Anderson Wing)
• National Hospital for Neurology and Neurosurgery
• Royal National ENT and Eastman Dental Hospitals
• University College Hospital Grafton Way Building
• Royal London Hospital for Integrated Medicine
• University College Hospital Macmillan Cancer Centre
• The Hospital for Tropical Diseases
• University College Hospital at Westmoreland Street
We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women’s health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.
We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.
For the full Person Specification and more information regarding the main responsibilities of this role, please refer to the attached Job Description.
Please note, due to anticipated high volumes of applications, this vacancy may close earlier than the listed closing date. You are advised not to delay submitting your completed application
The TYA Service at UCLH is the largest in the world, attracting an international
reputation, with regular visits from experts from around the globe. We provide
comprehensive tertiary care for patients from diagnosis, through to survivorship or palliative care. We provide all aspects of state-of-the-art cancer care and are a quaternary centre for specific treatments, including radio-isotope therapy and proton beam therapy. The clinical service is enhanced by exceptional clinical and translational research based within University College London and the Institute of Child Health.
All patients aged 0-18 years with a diagnosis of cancer, within the North Thames TYA Cancer Network are referred into the UCLH/GOSH Principal Treatment Centre. Patients aged 19-24 years are offered the choice to be referred to UCLH or to be treated at local Designated Hospitals within the Operational Delivery Network (ODN).
The newly opened Grafton Way Hospital houses the Proton Beam Therapy (PBT) Centre, one of only two sites in the UK. PBT offers innovative radiotherapy for certain cancer patients, with children making a significant proportion providing new models of care, synergistic clinical provision and research opportunities. These children require extensive supportive and POSCU-like care, offering opportunities for the development of
new services linking acute paediatrics, CYPCS and radiotherapy.
Come and be a part of the best NHS trust in England to work for, according to our staff*
* UCLH top trust to work at in England - In the most recent NHS staff survey UCLH had the highest percentage of staff who said they would recommend us as a place to work, out of all general acute or acute/community NHS trusts in England – for the third year in a row.
UCLH recognises the benefits of flexible working for staff – To find out more, visit: Flexible working.
To discover more about what makes UCLH a great place to work, visit: Why Choose UCLH?
This advert closes on Sunday 1 Feb 2026
Proud member of the Disability Confident employer scheme
Disability Confident
About Disability Confident
A Disability Confident employer will generally offer an interview to any applicant that declares they have a disability and meets the minimum criteria for the job as defined by the employer. It is important to note that in certain recruitment situations such as high-volume, seasonal and high-peak times, the employer may wish to limit the overall numbers of interviews offered to both disabled people and non-disabled people. For more details please go to Disability Confident.